Harnessing a germ‑free mouse gut bioreactor for directed evolution of probiotics to combat non-alcoholic fatty liver disease.
- 2026-02-24
- Nature communications 17(1)
- Zhe Han
- Zheng Sun
- Xinlei Liu
- Dongyu Zhen
- Quan Guo
- Leijie Zheng
- Shuaiming Jiang
- Zeng Zhang
- Siyuan Shen
- Jiachao Zhang
- PubMed: 41735321
- DOI: 10.1038/s41467-026-69823-0
- Moderate evidence
- Rigorous Journal
the adapted strain significantly improves bile-acid homeostasis, reduces hepatic steatosis, lowers inflammatory and lipid biomarkers, and enhances histological liver health compared to the parental strain.
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes